Frank Scorpiniti, CEO of Rexall Pharma Plus, issued a statement this week applauding the Ontario government’s announcement that it will expand the role of pharmacists to provide more options for Ontarians’ healthcare needs.
With the Medicare Annual Election Period set to begin Oct. 15, Walgreens on Wednesday announced it will be a part of preferred pharmacy networks of four national Medicare Part D plan sponsors: Coventry, Humana, SmartD Rx and UnitedHealthcare.
According to Surescripts, almost 400,000 physicians — about 58% of all office-based doctors — were e-prescribing at the end of 2011. The net effect: About 36% of all prescriptions were sent electronically in 2011.
With healthcare reform on track to bring 32 million more Americans into the healthcare system in 2014, and with payers and patients looking for solutions to curb costs as the nation battles a shortage of primary care physicians and access to quality care, CVS Caremark’s role in reinventing pharmacy through its distinctive business model couldn’t be more imperative than it is today.
Specialty may be the fastest-growing segment, but it may also be the most complicated, as this segment is comprised of very complex medications to treat such serious diseases as cancer, multiple sclerosis and hemophilia.
The Food and Drug Administration has reviewed new data that indicated that budeprion XL (bupropion hydrochloride extended-release tablets) in the 300-mg strength, manufactured by Impax Labs and Teva Pharmaceuticals USA, is not therapeutically equivalent to Wellbutrin XL in the 300-mg strength.
In partnership with international regulatory and law enforcement agencies, the Food and Drug Administration on Thursday announced it had taken action against more than 4,100 Internet pharmacies that illegally sell unapproved drugs to consumers.
The National Community Pharmacists Association on Thursday commended a bipartisan group of 13 U.S. representatives for a letter they jointly sent to the Drug Enforcement Administration requesting “clarification, guidance and collaboration,” and suggesting that the federal agency’s efforts in addressing supply chain issues of controlled substances across Florida-based distribution centers and pharmacies may be inadvertently preventing patients from accessing certain prescription drugs for which they have legitimate medical needs and prescriptions.
“Drugs don’t work in patients who don’t take them.” Sounds simple enough. But that obvious truism, voiced by former U.S. surgeon general C. Everett Koop, fails to convince tens of millions of patients that they should take their prescription medicines through the full dosage regimen.
Rep. Mike Honda, D-Calif., of the Silicon Valley is preparing to introduce legislation that will create a new division within the Food and Drug Administration to govern fast-developing healthcare applications, according to a report published by Kaiser Health News last week.
More than 20,000 RxAlly member pharmacies — including independent pharmacies, regional chains and Walgreens — will begin accepting a new federally qualified Medicare Prescription Drug Plan, SmartD Rx, beginning Jan. 1, 2013.